Bristol-Myers Squibb and Abbott Laboratories suffered the most last year, shedding $1.4 billion and $1.3 billion in revenues, respectively.-------------------Revenues, are usually explained due to losing patent rights, old generation drug losing sales & quite rightly so to new targeted drugs, etc.I'm not so concerned with my own holdings of ABT. Their progressiveness is way trumping loss in revenue.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra